Literature DB >> 24215403

The clinical potential for koff-rate measurement in adoptive immunotherapy.

Magdalena Nauerth1, Bianca Weissbrich, Dirk H Busch.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24215403     DOI： 10.1586/1744666X.2013.855609

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  5 in total

Review 1.  Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells.

Authors:  Sara Hamdan; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2022-04-01       Impact factor: 3.402

Review 2.  Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?

Authors:  Maik Luu; Delphine Ammar; Paula Barbao; Chiara Bonini; Philippe Bousso; Christian J Buchholz; Monica Casucci; Biagio De Angelis; Emmanuel Donnadieu; David Espie; Beatrice Greco; Richard Groen; Johannes B Huppa; Chahrazade Kantari-Mimoun; Bruno Laugel; Mary Mantock; Janet L Markman; Emma Morris; Concetta Quintarelli; Michael Rade; Kristin Reiche; Alba Rodriguez-Garcia; Juan Roberto Rodriguez-Madoz; Eliana Ruggiero; Maria Themeli; Sonia Guedan; Michael Hudecek; Ibtissam Marchiq
Journal:  J Immunother Cancer       Date:  2022-05       Impact factor: 12.469

3.  Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection.

Authors:  Kilian Schober; Florian Voit; Simon Grassmann; Thomas R Müller; Joel Eggert; Sebastian Jarosch; Bianca Weißbrich; Patrick Hoffmann; Lisa Borkner; Enzo Nio; Lorenzo Fanchi; Christopher R Clouser; Aditya Radhakrishnan; Lorenz Mihatsch; Philipp Lückemeier; Justin Leube; Georg Dössinger; Ludger Klein; Michael Neuenhahn; Jennifer D Oduro; Luka Cicin-Sain; Veit R Buchholz; Dirk H Busch
Journal:  Nat Immunol       Date:  2020-03-16       Impact factor: 25.606

Review 4.  Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.

Authors:  Michael Hebeisen; Mathilde Allard; Philippe O Gannon; Julien Schmidt; Daniel E Speiser; Nathalie Rufer
Journal:  Front Immunol       Date:  2015-11-18       Impact factor: 7.561

Review 5.  TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals.

Authors:  Francesco Manfredi; Beatrice Claudia Cianciotti; Alessia Potenza; Elena Tassi; Maddalena Noviello; Andrea Biondi; Fabio Ciceri; Chiara Bonini; Eliana Ruggiero
Journal:  Front Immunol       Date:  2020-09-03       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.